Schedule 13G ownership disclosure
AVADEL PHARMACEUTICALS PLC
Security class unavailable · CUSIP: 05337M104
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 11,125,330
- Percent of class
- 12.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-24-000027
- Form type
- SC 13G
- Filer
- AVADEL PHARMACEUTICALS PLC
- CIK
- CIK 1012477
- Filed
- Feb 13, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership